Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRJ1-3024 in advanced solid tumors
NCT05315167Phase 2Recruiting
- Sponsor
- Zhuhai Yufan Biotechnologies Co., Ltd.
- Start
- May 2022
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of prj1-3024 in solid tumor (advanced stage), sponsored by Zhuhai Yufan Biotechnologies Co., Ltd.. Started May 2022; status: recruiting.
02
Drugs
prj1-3024
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT05315167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05315167.